Sep 13, 2021 / 12:30PM GMT
Operator
Good day and thank you for standing by. Welcome to the AzurRx BioPharma webcast and conference call.
(Operator Instructions)
I would now like to hand the conference over to your speaker today, Jason Rando, with Tiberend Strategic Advisers. Thank you and please go ahead.
Jason Rando - Tiberend Strategic Advisors, Inc. - Investor Relations
Good morning and thank you everyone for joining today's call to discuss AzurRx BioPharma's acquisition of First Wave Bio and the renaming of the company to First Wave BioPharma.
Before we begin, I would like to remind our listeners that remarks made during this call may contain forward-looking statements that involve risks and uncertainties and are subject to change at any time, including but not limited to statements about as AzurRx's expectations regarding future operating results. Forward-looking statements are made pursuant to the Safe Harbor provisions of the Federal Securities Laws and represent management's current expectations. Actual results may differ materially.
AzurRx disclaims
AzurRx BioPharma Inc Acquisition of First Wave Bio M&A Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot